WHO and ASCO Formed Cancer Care Partnership
The organizations signed an agreement to strengthen the global oncology workforce and improve access to cancer clinical trials.
Updated on Oct. 14, 2026 in Cancer
Live Poll
Do you believe international medical partnerships effectively improve cancer care access in lower-income countries?
The World Health Organization and the American Society of Clinical Oncology have signed a formal collaboration agreement to bolster cancer care worldwide. This partnership prioritizes improving health professional competencies, cancer trial access, and quality accountability in treatment.
Why it matters
The collaboration aims to address the significant burden of cancer, which affects an estimated 92% of families worldwide. By strengthening the global oncology workforce, the initiative seeks to improve survival rates and service quality.
A formal partnership agreement confirms that cancer currently impacts 92% of families worldwide. Implementation plans for oncology workforce development are now underway to address this global statistic.
The players
World Health Organization
This is a specialized agency of the United Nations responsible for international public health.
American Society of Clinical Oncology
This is a professional organization representing physicians and oncology professionals who care for people living with cancer.
The details
The partners will utilize both virtual and in-person training initiatives to expand oncology workforce capacity, with programs developed in consultation with WHO Member States. These efforts are tailored to individual country contexts, specifically focusing on healthcare improvements in low- and middle-income nations.
Timeline
The World Health Organization released its Global status report on cancer in 2026.
The collaboration agreement was signed on October 14, 2026.
The Big Picture
This partnership represents an operational expansion following the data trends established in the WHO Global status report on cancer.
This initiative aims to improve local access to high-quality clinical trials and specialized cancer care, particularly in underserved regions. Patients may eventually see increased availability of trained oncology professionals and more standardized treatment protocols in their home countries.
The takeaway
Collaborative international efforts are essential to standardizing oncology care across diverse healthcare systems. Patients in regions with limited resources stand to benefit most from standardized training and improved clinical trial infrastructure.
Further reading
For more information on ongoing global research and treatment trends, visit the Cancer section.
Live Poll
Do you believe international medical partnerships effectively improve cancer care access in lower-income countries?
